| Year |
Citation |
Score |
| 2022 |
Tsai FJ, Nelson LT, Kline GM, Jäger M, Berk JL, Sekijima Y, Powers ET, Kelly JW. Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-5. PMID 36444793 DOI: 10.1080/13506129.2022.2148094 |
0.621 |
|
| 2020 |
Mizuno H, Hoshino J, So M, Kogure Y, Fujii T, Ubara Y, Takaichi K, Nakaniwa T, Tanaka H, Kurisu G, Kametani F, Nakagawa M, Yoshinaga T, Sekijima Y, Higuchi K, et al. Dialysis-related amyloidosis associated with a novel β-microglobulin variant. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-8. PMID 32875920 DOI: 10.1080/13506129.2020.1813097 |
0.33 |
|
| 2020 |
Ishii T, Hirano Y, Matsumoto N, Takata A, Sekijima Y, Ueda M, Ando Y. Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance. Clinical Therapeutics. PMID 32800381 DOI: 10.1016/J.Clinthera.2020.07.001 |
0.325 |
|
| 2020 |
Hayashida A, Li Y, Yoshino H, Daida K, Ikeda A, Ogaki K, Fuse A, Mori A, Takanashi M, Nakahara T, Yoritaka A, Tomizawa Y, Furukawa Y, Kanai K, Nakayama Y, ... ... Sekijima Y, et al. The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1. Neurobiology of Aging. PMID 32713623 DOI: 10.1016/J.Neurobiolaging.2020.06.017 |
0.31 |
|
| 2020 |
Ushiyama S, Shimojima Y, Ueno KI, Kishida D, Miyazaki D, Sekijima Y. Clinical characteristics of patients with myalgia as the initial manifestation of small and medium-sized vasculitis: a retrospective study. Rheumatology International. PMID 32710199 DOI: 10.1007/S00296-020-04652-Y |
0.329 |
|
| 2020 |
Kishida D, Sakaguchi N, Ueno KI, Ushiyama S, Ichikawa T, Yoshinaga T, Shimojima Y, Sekijima Y. Macrophage activation syndrome in adult dermatomyositis: a case-based review. Rheumatology International. PMID 32356114 DOI: 10.1007/S00296-020-04590-9 |
0.351 |
|
| 2020 |
Ueda M, Sekijima Y, Koike H, Yamashita T, Yoshinaga T, Ishii T, Ando Y. Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies. Journal of the Neurological Sciences. 414: 116813. PMID 32353608 DOI: 10.1016/J.Jns.2020.116813 |
0.336 |
|
| 2020 |
Ichikawa T, Shimojima Y, Kishida D, Kaneko T, Sekijima Y. Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review. Rheumatology International. PMID 32253501 DOI: 10.1007/S00296-020-04569-6 |
0.308 |
|
| 2020 |
Naiki H, Sekijima Y, Ueda M, Ohashi K, Hoshii Y, Shimoda M, Ando Y. Human amyloidosis, still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics. Pathology International. PMID 31961039 DOI: 10.1111/Pin.12902 |
0.376 |
|
| 2020 |
Ichimata S, Hata Y, Abe R, Yoshinaga T, Katoh N, Kametani F, Yazaki M, Sekijima Y, Ehara T, Nishida N. An autopsy case of amyloid tubulopathy exhibiting characteristic spheroid-type deposition. Virchows Archiv : An International Journal of Pathology. PMID 31932919 DOI: 10.1007/S00428-019-02740-4 |
0.357 |
|
| 2020 |
Yamashita T, Ueda M, Sekijima Y, Yoshinaga T, Kodaira M, Koike H, Katsuno M, Sobue G, Zhang X, White MT, Sweetser MT, Wang JJ, Ando Y. Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: sub‐analysis in Japanese patients from the APOLLO study Neurology and Clinical Neuroscience. DOI: 10.1111/Ncn3.12396 |
0.313 |
|
| 2019 |
Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, Kuwahara K, Inomata T, Ueda M, Sekijima Y, Ando Y, Tsutsui H, Isobe M, Fukuda K. A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. Circulation Journal : Official Journal of the Japanese Circulation Society. PMID 31735731 DOI: 10.1253/Circj.Cj-19-0811 |
0.355 |
|
| 2019 |
Hosoi T, Ishii K, Tozaka N, Kishida D, Sekijima Y, Tamaoka A. Familial Mediterranean Fever is Important in the Differential Diagnosis of Recurrent Aseptic Meningitis in Japan. Internal Medicine (Tokyo, Japan). PMID 31511485 DOI: 10.2169/Internalmedicine.3432-19 |
0.347 |
|
| 2019 |
Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine. Internal Medicine (Tokyo, Japan). PMID 31391399 DOI: 10.2169/Internalmedicine.2929-19 |
0.319 |
|
| 2019 |
Yamada Y, Fukushima T, Kodama S, Shimizu H, Kakita A, Makino K, Sekijima Y. A case of cerebral amyloid angiopathy-type hereditary ATTR amyloidosis with Y69H (p.Y89H) variant displaying transient focal neurological episodes as the main symptom. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-2. PMID 31257920 DOI: 10.1080/13506129.2019.1632829 |
0.313 |
|
| 2019 |
Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y. Late-onset familial Mediterranean fever in Japan. Modern Rheumatology. 1-11. PMID 31116049 DOI: 10.1080/14397595.2019.1621440 |
0.325 |
|
| 2019 |
Ogawa Y, Nakamura K, Ezawa N, Yamaguchi T, Yoshinaga T, Miyazaki D, Kosho T, Sekijima Y. A novel CACNA1A nonsense variant in a patient presenting with paroxysmal exertion-induced dyskinesia. Journal of the Neurological Sciences. 399: 214-216. PMID 30852237 DOI: 10.1016/J.Jns.2019.02.040 |
0.314 |
|
| 2019 |
Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, Sipe JD, Westermark P. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-5. PMID 30614283 DOI: 10.1080/13506129.2018.1549825 |
0.374 |
|
| 2018 |
Shintani Y, Okada A, Morita Y, Hamatani Y, Amano M, Takahama H, Amaki M, Hasegawa T, Ohta-Ogo K, Kanzaki H, Ishibashi-Ueda H, Yasuda S, Shimazaki C, Yoshinaga T, Yazaki M, ... Sekijima Y, et al. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy. Esc Heart Failure. PMID 30478886 DOI: 10.1002/Ehf2.12382 |
0.346 |
|
| 2018 |
Miyake Z, Nakamagoe K, Ezawa N, Yoshinaga T, Hashimoto R, Sato T, Sekijima Y, Tamaoka A. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Internal Medicine (Tokyo, Japan). PMID 30333406 DOI: 10.2169/Internalmedicine.1457-18 |
0.383 |
|
| 2018 |
Tanaka R, Shimojima Y, Moteki H, Kishida D, Ueno KI, Sekijima Y. Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Internal Medicine (Tokyo, Japan). PMID 29780146 DOI: 10.2169/Internalmedicine.0944-18 |
0.302 |
|
| 2018 |
Akagawa Y, Ueno A, Ikeda J, Ishii W, Shishido-Hara Y, Sekijima Y. [Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone]. Rinsho Shinkeigaku = Clinical Neurology. PMID 29710027 DOI: 10.5692/Clinicalneurol.Cn-001166 |
0.314 |
|
| 2018 |
Yazaki M, Yoshinaga T, Sekijima Y, Kametani F, Okumura N. Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics. International Journal of Molecular Sciences. 19. PMID 29361747 DOI: 10.3390/Ijms19010320 |
0.318 |
|
| 2018 |
Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet Journal of Rare Diseases. 13: 6. PMID 29343286 DOI: 10.1186/S13023-017-0726-X |
0.321 |
|
| 2018 |
Sekijima Y, Koyama S, Yoshinaga T, Koinuma M, Inaba Y. Nationwide survey on cerebrotendinous xanthomatosis in Japan. Journal of Human Genetics. PMID 29321515 DOI: 10.1038/S10038-017-0389-4 |
0.324 |
|
| 2018 |
Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. Internal Medicine (Tokyo, Japan). 57: 181-187. PMID 29093404 DOI: 10.2169/Internalmedicine.9206-17 |
0.329 |
|
| 2017 |
Kishida D, Yazaki M, Nakamura A, Nomura F, Kondo T, Uehara T, Ikusaka M, Ohya A, Watanabe N, Endo R, Kawaai S, Shimojima Y, Sekijima Y. One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study. Rheumatology International. PMID 29151129 DOI: 10.1007/S00296-017-3886-Z |
0.351 |
|
| 2017 |
Yoshinaga T, Nakamura K, Ishikawa M, Yamaguchi T, Takano K, Wakui K, Kosho T, Yoshida K, Fukushima Y, Sekijima Y. A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8. Human Genome Variation. 4: 17052. PMID 29081981 DOI: 10.1038/Hgv.2017.52 |
0.314 |
|
| 2017 |
Schonhoft JD, Monteiro C, Plate L, Eisele YS, Kelly JM, Boland D, Parker CG, Cravatt BF, Teruya S, Helmke S, Maurer M, Berk J, Sekijima Y, Novais M, Coelho T, et al. Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients. Science Translational Medicine. 9. PMID 28904227 DOI: 10.1126/Scitranslmed.Aam7621 |
0.761 |
|
| 2017 |
Shimojima Y, Kishida D, Sekijima Y. Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis. Cytokine. PMID 28847534 DOI: 10.1016/J.Cyto.2017.08.013 |
0.303 |
|
| 2017 |
Kano Y, Kodaira M, Ushiki A, Kosaka M, Yamada M, Shingu K, Nishihara H, Hanaoka M, Sekijima Y. The Complete Remission of Acquired Immunodeficiency Syndrome-associated Isolated Central Nervous System Lymphomatoid Granulomatosis: A Case Report and Review of the Literature. Internal Medicine (Tokyo, Japan). PMID 28824078 DOI: 10.2169/Internalmedicine.8776-16 |
0.304 |
|
| 2017 |
Kobayashi Y, Shimojima Y, Kondo Y, Takamatsu R, Miyazaki D, Kishida D, Sekijima Y, Ikeda SI. Protein-losing Gastroenteropathy Related to Mixed Connective Tissue Disease: A Case Report of a Successful Outcome and Literature Review. Internal Medicine (Tokyo, Japan). 56: 2057-2062. PMID 28768981 DOI: 10.2169/Internalmedicine.56.8391 |
0.356 |
|
| 2017 |
Shimada H, Shoji M, Ikeuchi T, Suzuki K, Senda M, Ishii K, Matsuda H, Iwata A, Ihara R, Iwatsubo T, Mutoh K, Nakazawa E, Sekijima Y, Mori E, Ikeda M, et al. [DIAN/DIAN-J/DIAN-TU]. Brain and Nerve = Shinkei Kenkyu No Shinpo. 69: 701-709. PMID 28739983 DOI: 10.11477/Mf.1416200811 |
0.353 |
|
| 2017 |
Nagamatsu K, Sekijima Y, Nakamura K, Nakamura K, Hattori K, Ota M, Shimizu Y, Endo F, Ikeda SI. Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients. Journal of Human Genetics. PMID 28275245 DOI: 10.1038/Jhg.2017.31 |
0.315 |
|
| 2017 |
Fujita T, Inomata T, Kaida T, Iida Y, Ikeda Y, Nabeta T, Ishii S, Maekawa E, Naruke T, Koitabashi T, Kitamura E, Sekijima Y, Ako J. Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report. Cardiology. 137: 74-77. PMID 28152524 DOI: 10.1159/000455089 |
0.357 |
|
| 2017 |
Yoshinaga T, Yazaki M, Kametani F, Sekijima Y, Iesato Y, Miyahara T, Tsuchiya-Suzuki A, Sano K, Higuchi K, Ikeda SI. Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-7. PMID 28081655 DOI: 10.1080/13506129.2016.1276055 |
0.371 |
|
| 2017 |
Ogawa Y, Nakagawa M, Yoshida T, Yazaki M, Sekijima Y, Hashimoto T, Ikeda S. Survey of epidemiology, clinical picture and current treatments for elderly-onset (≥ 65 years) patients with myasthenia gravis in Nagano Prefecture, Japan Neurology and Clinical Neuroscience. 5: 107-112. DOI: 10.1111/Ncn3.12129 |
0.312 |
|
| 2017 |
Hayashida A, Li Y, Yoshino H, Nakahara T, Yoritaka A, Nagara Y, Sakiyama Y, Kusaka H, Takiyama Y, Morimoto N, Uchino A, Fujimoto T, Sekijima Y, Tomimoto H, Tsuruta K, et al. Pink1 heterozygous mutations in familial Parkinson's disease Journal of the Neurological Sciences. 381: 161-162. DOI: 10.1016/J.Jns.2017.08.473 |
0.313 |
|
| 2017 |
Katoh N, Abe R, Ezawa N, Miyazaki D, Sekijima Y. Amyloid myopathy: Diagnosis, clinical presentation, pathology, and amyloid imaging findings of this rare myopathy associated with systemic immunoglobulin light-chain (AL) amyloidosis Journal of the Neurological Sciences. 381: 472. DOI: 10.1016/J.Jns.2017.08.3540 |
0.329 |
|
| 2017 |
Kodama S, Miyazaki D, Yoshinaga T, Yazaki M, Sekijima Y. Clinical characteristics of ATTR-type leptomeningeal amyloidosis/cerebral amyloid angiopathy Journal of the Neurological Sciences. 381: 383. DOI: 10.1016/J.Jns.2017.08.3297 |
0.312 |
|
| 2017 |
Yazaki M, Yoshinaga T, Sekijima Y, Kametani F. Pathomechanism of progression of ocular and CNS amyloidosis in liver-transplanted familial amyloid polyneuropathy (FAP) patients Journal of the Neurological Sciences. 381: 971. DOI: 10.1016/J.Jns.2017.08.2736 |
0.315 |
|
| 2016 |
Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, Yahikozawa H, Watanabe M, Kametani F, Ikeda SI. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. PMID 27466465 DOI: 10.1212/Wnl.0000000000003001 |
0.312 |
|
| 2016 |
Ueno KI, Shimojima Y, Kishida D, Sekijima Y, Ikeda SI. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. International Journal of Rheumatic Diseases. PMID 27457756 DOI: 10.1111/1756-185X.12931 |
0.303 |
|
| 2016 |
Ohara S, Hagihara M, Hua J, Inoue M, Uchida T, Yoshinaga T, Yazaki M, Sekijima Y, Kametani F. Recurrence of Waldenström macroglobulinemia accompanied by factor X deficiency. [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology. 57: 359-63. PMID 27076250 DOI: 10.11406/Rinketsu.57.359 |
0.305 |
|
| 2016 |
Nakagawa M, Sekijima Y, Yazaki M, Tojo K, Yoshinaga T, Doden T, Koyama J, Yanagisawa S, Ikeda SI. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-6. PMID 26852880 DOI: 10.3109/13506129.2015.1135792 |
0.314 |
|
| 2015 |
Sekijima Y, Campos RI, Hammarström P, Nilsson KP, Yoshinaga T, Nagamatsu K, Yazaki M, Kametani F, Ikeda SI. Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype. Journal of the Peripheral Nervous System : Jpns. PMID 26306725 DOI: 10.1111/Jns.12143 |
0.671 |
|
| 2015 |
Yazaki M, Yoshinaga T, Sekijima Y, Nishio S, Kanizawa Y, Kametani F, Miyashita K, Hachiya N, Higuchi K, Ikeda SI. The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen Aα-chain amyloidosis associated with a novel frameshift variant. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-3. PMID 26017329 DOI: 10.3109/13506129.2015.1037389 |
0.317 |
|
| 2015 |
Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25604431 DOI: 10.1136/Jnnp-2014-308724 |
0.439 |
|
| 2014 |
Sekijima Y. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy]. Rinshō Shinkeigaku = Clinical Neurology. 54: 953-6. PMID 25672679 DOI: 10.5692/Clinicalneurol.54.953 |
0.41 |
|
| 2014 |
Yoshinaga T, Sekijima Y, Koyama S, Maruyama K, Yoshida T, Kato T, Ikeda S. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene. Internal Medicine (Tokyo, Japan). 53: 2725-9. PMID 25447658 DOI: 10.2169/Internalmedicine.53.2996 |
0.325 |
|
| 2014 |
Uchiyama S, Sekijima Y, Tojo K, Sano K, Imaeda T, Moriizumi T, Ikeda S, Kato H. Effect of synovial transthyretin amyloid deposition on preoperative symptoms and postoperative recovery of median nerve function among patients with idiopathic carpal tunnel syndrome. Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association. 19: 913-9. PMID 25146002 DOI: 10.1007/S00776-014-0635-Y |
0.333 |
|
| 2014 |
Nakamura K, Sekijima Y, Nakamura K, Hattori K, Nagamatsu K, Shimizu Y, Yazaki M, Sakurai A, Endo F, Fukushima Y, Ikeda SI. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 21: 49-56. PMID 23724928 DOI: 10.1111/Ene.12214 |
0.321 |
|
| 2013 |
Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. Jama. 310: 2658-67. PMID 24368466 DOI: 10.1001/Jama.2013.283815 |
0.51 |
|
| 2013 |
Kobayashi A, Uhara H, Kido K, Sekijima Y, Tojo K, Ikeda S, Okuyama R. Bullous formation in a patient with familial amyloid polyneuropathy type I. International Journal of Dermatology. 52: 1398-400. PMID 24164154 DOI: 10.1111/J.1365-4632.2011.05146.X |
0.366 |
|
| 2013 |
Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, Kametani F, Ikeda S. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 156-63. PMID 23826783 DOI: 10.3109/13506129.2013.807790 |
0.367 |
|
| 2013 |
Nakagawa M, Sekijima Y, Tojo K, Ikeda S. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 138-40. PMID 23638696 DOI: 10.3109/13506129.2013.790809 |
0.376 |
|
| 2013 |
Sekijima Y, Nakamura K, Kishida D, Narita A, Adachi K, Ohno K, Nanba E, Ikeda S. Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene. Internal Medicine (Tokyo, Japan). 52: 119-24. PMID 23291686 DOI: 10.2169/Internalmedicine.52.8901 |
0.323 |
|
| 2012 |
Berk JL, Suhr OB, Sekijima Y, Yamashita T, Heneghan M, Zeldenrust SR, Ando Y, Ikeda S, Gorevic P, Merlini G, Kelly JW, Skinner M, Bisbee AB, Dyck PJ, Obici L, et al. The Diflunisal Trial: study accrual and drug tolerance. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 19: 37-8. PMID 22551208 DOI: 10.3109/13506129.2012.678509 |
0.529 |
|
| 2012 |
Nakamura A, Hineno A, Yoshida K, Sekijima Y, Hanaoka-Tachibana N, Takei Y, Ohara S, Ikeda S. Marked intrafamilial phenotypic variation in a family with SOD1 C111Y mutation. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 479-86. PMID 22409359 DOI: 10.3109/17482968.2011.656311 |
0.361 |
|
| 2012 |
Miyamura M, Terasaki F, Ishibashi K, Shimazaki C, Kimura F, Kuwabara H, Tsuji M, Shibayama Y, Sekijima Y, Tojo K, Ishizaka N. Two siblings diagnosed to have transthyretin-related familial amyloid cardiomyopathy around the same time at different hospitals. Internal Medicine (Tokyo, Japan). 51: 465-9. PMID 22382560 DOI: 10.2169/Internalmedicine.51.6369 |
0.337 |
|
| 2011 |
Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 211-5. PMID 22004460 DOI: 10.3109/13506129.2011.623199 |
0.358 |
|
| 2011 |
Berk JL, Dyck PJ, Obici L, Zeldenrust SR, Sekijima Y, Yamashita T, Ando Y, Ikeda SI, Gorevic P, Merlini G, Kelly JW, Skinner M, Bisbee AB, Suhr OB. The diflunisal trial: update on study drug tolerance and disease progression. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 196-7. PMID 21838485 DOI: 10.3109/13506129.2011.574354073 |
0.484 |
|
| 2011 |
Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, Hoshii Y, Kato H, Ikeda S. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Human Pathology. 42: 1785-91. PMID 21733562 DOI: 10.1016/J.Humpath.2011.03.004 |
0.334 |
|
| 2011 |
Yokoseki A, Ishihara T, Koyama A, Shiga A, Yamada M, Suzuki C, Sekijima Y, Maruta K, Tsuchiya M, Date H, Sato T, Tada M, Ikeuchi T, Tsuji S, Nishizawa M, et al. Genotype-phenotype correlations in early onset ataxia with ocular motor apraxia and hypoalbuminaemia. Brain : a Journal of Neurology. 134: 1387-99. PMID 21486904 DOI: 10.1093/Brain/Awr069 |
0.311 |
|
| 2011 |
Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Human Pathology. 42: 236-43. PMID 21056899 DOI: 10.1016/J.Humpath.2010.06.014 |
0.406 |
|
| 2010 |
Sekijima Y. Familial amyloid polyneuropathy: diflunisal. Rinshō Shinkeigaku = Clinical Neurology. 50: 836. PMID 21921462 DOI: 10.5692/Clinicalneurol.50.836 |
0.429 |
|
| 2010 |
Sekijima Y, Yoshida T, Ikeda S. CPPD crystal deposition disease of the cervical spine: a common cause of acute neck pain encountered in the neurology department. Journal of the Neurological Sciences. 296: 79-82. PMID 20646716 DOI: 10.1016/J.Jns.2010.05.028 |
0.333 |
|
| 2010 |
Nakamura K, Sekijima Y, Nakamura K, Hattori K, Nagamatsu K, Shimizu Y, Yasude T, Ushiyama M, Endo F, Fukushima Y, Ikeda S. Cerebral hemorrhage in Fabry's disease. Journal of Human Genetics. 55: 259-61. PMID 20300124 DOI: 10.1038/Jhg.2010.18 |
0.328 |
|
| 2010 |
Tojo K, Tsuchiya-Suzuki A, Sekijima Y, Morita H, Sumita N, Ikeda S. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 17: 32-5. PMID 20132088 DOI: 10.3109/13506121003619369 |
0.344 |
|
| 2009 |
Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, Suhr OB, Ando Y. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clinical Chemistry. 55: 1223-7. PMID 19372189 DOI: 10.1373/Clinchem.2008.118505 |
0.335 |
|
| 2008 |
Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Current Pharmaceutical Design. 14: 3219-30. PMID 19075702 DOI: 10.2174/138161208786404155 |
0.557 |
|
| 2008 |
Naito KS, Sekijima Y, Ikeda S. Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 15: 275-7. PMID 19065301 DOI: 10.1080/13506120802524981 |
0.34 |
|
| 2008 |
Tojo K, Sekijima Y, Machida K, Tsuchiya A, Yazaki M, Ikeda S. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy. Muscle & Nerve. 37: 796-803. PMID 18506713 DOI: 10.1002/Mus.21028 |
0.372 |
|
| 2006 |
Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 13: 236-49. PMID 17107884 DOI: 10.1080/13506120600960882 |
0.52 |
|
| 2006 |
Tojo K, Sekijima Y, Kelly JW, Ikeda S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neuroscience Research. 56: 441-9. PMID 17028027 DOI: 10.1016/J.Neures.2006.08.014 |
0.555 |
|
| 2006 |
Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 13: 57-66. PMID 16911959 DOI: 10.1080/13506120600722449 |
0.783 |
|
| 2005 |
Mitsuhashi S, Yazaki M, Tokuda T, Sekijima Y, Washimi Y, Shimizu Y, Ando Y, Benson MD, Ikeda S. Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 12: 216-25. PMID 16399646 DOI: 10.1080/13506120500352404 |
0.371 |
|
| 2005 |
Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Accounts of Chemical Research. 38: 911-21. PMID 16359163 DOI: 10.1021/Ar020073I |
0.758 |
|
| 2005 |
Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW. The biological and chemical basis for tissue-selective amyloid disease. Cell. 121: 73-85. PMID 15820680 DOI: 10.1016/J.Cell.2005.01.018 |
0.729 |
|
| 2004 |
Matsubara E, Sekijima Y, Tokuda T, Urakami K, Amari M, Shizuka-Ikeda M, Tomidokoro Y, Ikeda M, Kawarabayashi T, Harigaya Y, Ikeda S, Murakami T, Abe K, Otomo E, Hirai S, et al. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins. Neurobiology of Aging. 25: 833-41. PMID 15212837 DOI: 10.1016/J.Neurobiolaging.2003.10.004 |
0.344 |
|
| 2004 |
Miller SR, Sekijima Y, Kelly JW. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Laboratory Investigation; a Journal of Technical Methods and Pathology. 84: 545-52. PMID 14968122 DOI: 10.1038/Labinvest.3700059 |
0.557 |
|
| 2003 |
Kato T, Hoshi K, Sekijima Y, Matsuda M, Hashimoto T, Otani M, Suzuki A, Ikeda S. Rheumatoid meningitis: an autopsy report and review of the literature. Clinical Rheumatology. 22: 475-80. PMID 14677033 DOI: 10.1007/S10067-003-0788-0 |
0.309 |
|
| 2003 |
Sekijima Y, Hashimoto T, Onodera O, Date H, Okano T, Naito K, Tsuji S, Ikeda S. Severe generalized dystonia as a presentation of a patient with aprataxin gene mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1198-200. PMID 14534929 DOI: 10.1002/Mds.10526 |
0.314 |
|
| 2003 |
Hammarström P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry. 42: 6656-63. PMID 12779320 DOI: 10.1021/Bi027319B |
0.785 |
|
| 2003 |
Sekijima Y, Hammarström P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly JW. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 409-17. PMID 12649341 DOI: 10.1097/01.Lab.0000059937.11023.1F |
0.722 |
|
| 2001 |
Sekijima Y, Tokuda T, Kametani F, Tanaka K, Maruyama K, Ikeda S. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 8: 257-62. PMID 11791618 DOI: 10.3109/13506120108993822 |
0.409 |
|
| 2001 |
Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, Takahashi T, Nagatomo H, Sekijima Y, Kawachi I, et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nature Genetics. 29: 184-8. PMID 11586299 DOI: 10.1038/Ng1001-184 |
0.34 |
|
| 2000 |
Ishikawa S, Ishikawa M, Tokuda T, Yoshida K, Wakui K, Matsuura S, Ohara S, Sekijima Y, Hidaka E, Fukushima Y, Shigeta H, Komatsu K, Ikeda S. Japanese family with an autosomal dominant chromosome instability syndrome: a new neurodegenerative disease? American Journal of Medical Genetics. 94: 265-70. PMID 11038437 DOI: 10.1002/1096-8628(20001002)94:4<265::Aid-Ajmg1>3.0.Co;2-# |
0.313 |
|
| 1998 |
Sekijima Y, Ikeda S, Tokuda T, Satoh S, Hidaka H, Hidaka E, Ishikawa M, Yanagisawa N. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. European Neurology. 39: 234-7. PMID 9635475 DOI: 10.1159/000007940 |
0.339 |
|
| 1997 |
Tokuda T, Fukushima T, Ikeda S, Sekijima Y, Shoji S, Yanagisawa N, Tamaoka A. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Annals of Neurology. 41: 271-3. PMID 9029078 DOI: 10.1002/Ana.410410220 |
0.339 |
|
| 1996 |
Satoh S, Tokuda T, Ikeda S, Sekijima Y, Yanagisawa N, Hidaka H, Kametani F. No association between apolipoprotein E epsilon4 allele and the age of onset in type I familial amyloid polyneuropathy. Neuroscience Letters. 204: 209-11. PMID 8938267 DOI: 10.1016/0304-3940(96)12344-2 |
0.367 |
|
| Show low-probability matches. |